| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $20,023,603 ) (Continued on the next page) |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI180610 | Enhancing memory T cell defense in the female reproductive tract. | 001 | 1 | NIH | 11/20/2023 | $0 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31DK126467 | Investigating the impact of collagenase in Clostridioides difficile pathogenesis | 000 | 3 | NIH | 11/28/2023 | $47,694 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH117103 | Integrated mechanisms for orbitofrontal cortical control of memory and choice | 001 | 6 | NIH | 11/15/2023 | $608,117 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01EB027774 | Coronary Fractional Flow Reserve Determined Using MRI and CFD | 000 | 4 | NIH | 12/5/2023 | $296,198 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC021478 | Dissecting the first layer of central taste processing in Drosophila | 000 | 1 | NIH | 10/19/2023 | $366,136 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA281148 | Targeting PGC1?/PPAR? axis for overcoming acquired resistant to third generation EGFR-TKIs | 000 | 1 | NIH | 11/24/2023 | $474,087 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01HL150658 | Neutrophil hyperexocytosis and hypochlorous acid exposure in early cystic fibrosis lung disease | 000 | 2 | NIH | 11/3/2023 | $385,205 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA277686 | Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma | 000 | 2 | NIH | 11/3/2023 | $321,306 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | H7607848 | Ryan White Part C Outpatient EIS Program | 00 | 18 | HRSA | 11/16/2023 | $161,058 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA276135 | Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML | 000 | 1 | NIH | 11/23/2023 | $554,143 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA275964 | Targeting leukemic stem cells in acute myeloid leukemia | 000 | 2 | NIH | 11/15/2023 | $379,943 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | K23AG084851 | The Brain Health of Transgender and Gender Diverse Adults: An Examination of Alzheimer?s Disease and Related Dementias Risk and Psychosocial Stressors | 000 | 1 | NIH | 11/10/2023 | $196,344 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI172452 | Mechano-ID for tagging immune cells | 001 | 2 | NIH | 11/15/2023 | $343,134 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | K23AG076977 | Midlife Vascular Risk Factors for Alzheimer's Disease in Persons with HFpEF | 000 | 2 | NIH | 11/6/2023 | $192,780 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | K22CA266739 | Revealing the cis-Regulatory Function of IMiDs in Multiple Myeloma?. | 000 | 2 | NIH | 11/3/2023 | $187,448 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES033603 | Gene-Environment interactions in Autism | 000 | 3 | NIH | 11/28/2023 | $609,438 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI167724 | Optimizing AAV delivery of bNAbs for HIV prevention | 000 | 3 | NIH | 10/24/2023 | $818,054 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES032440 | Interaction of Pyrethroid Exposure and the Microbiome on Parkinson's Disease related Pathologies | 000 | 3 | NIH | 11/28/2023 | $347,629 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI166305 | Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment | 000 | 3 | NIH | 11/16/2023 | $1,017,263 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI165644 | Impact of intra-host population structure on influenza virus antigenic evolution | 000 | 3 | NIH | 11/8/2023 | $347,180 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AG080262 | PET imaging of ionotropic glutamate receptor signaling in Alzheimer's disease | 000 | 2 | NIH | 11/17/2023 | $176,063 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI148684 | Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) | 000 | 5 | NIH | 11/29/2023 | $468,492 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI148471 | Epigenetic instruction of memory B cell function and reactivation | 000 | 5 | NIH | 11/13/2023 | $348,320 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | K12ES033593 | Pediatric and Reproductive Environmental Health Scholars Southeastern Environmental Exposures and Disparities (PREHS SEED) Program | 000 | 3 | NIH | 11/22/2023 | $485,387 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES027859 | Mechanisms of transgenerational epigenetic inheritance | 001 | 7 | NIH | 10/18/2023 | $503,096 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI112787 | Targeting PD-1 Pathway for Functional Cure of AIDS | 000 | 11 | NIH | 11/14/2023 | $837,698 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31HL168949 | Roles for integrins in control of lung barrier function | 000 | 1 | NIH | 11/20/2023 | $47,694 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI148684 | Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) | 000 | 5 | NIH | 11/29/2023 | $5,370,097 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148217 | The Gut as a Target to Improve Outcomes in Sepsis | 001 | 2 | NIH | 11/27/2023 | $42,781 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI148576 | Vaccine and Treatment Evaluation Units | 000 | 5 | NIH | 11/15/2023 | $500,400 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148217 | The Gut as a Target to Improve Outcomes in Sepsis | 000 | 2 | NIH | 11/20/2023 | $478,890 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI148576 | Vaccine and Treatment Evaluation Units | 000 | 5 | NIH | 11/15/2023 | $581,245 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 000 | 18 | NIH | 11/8/2023 | $317,437 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R34MH129187 | Brothers building brothers by breaking barriers (B6): A resilience-focused intervention for young Black gay and bisexual men living with HIV | 000 | 3 | NIH | 11/28/2023 | $211,140 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 000 | 18 | NIH | 11/8/2023 | $1,441,699 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21ES034190 | Modification of temperature-morbidity associations by social determinants of health: the use of Z-coding | 000 | 2 | NIH | 11/28/2023 | $192,877 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | U24ES028507 | Enriching the Rhode Island Child Health Study | 000 | 7 | NIH | 10/23/2023 | $379,833 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21CA277103 | Dissecting pemetrexed resistance in non-small cell lung carcinoma | 000 | 2 | NIH | 11/6/2023 | $197,542 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG079956 | Subtype-selective phosphodiesterase PET ligands | 000 | 2 | NIH | 11/28/2023 | $699,600 |
| 2024 | 2024 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI180610 | Enhancing memory T cell defense in the female reproductive tract. | 000 | 1 | NIH | 11/9/2023 | $211,275 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31CA271764 | Interrogating the Fgl2-Fc?RIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells | 000 | 1 | NIH | 10/20/2023 | -$20,371 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG061179 | Burden, correlates, and outcomes of poor cognitive and physical functioning in the lupus population | 000 | 5 | NIH | 11/9/2023 | -$205,735 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AT012140 | Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry | 001 | 2 | NIH | 12/5/2023 | $0 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AT012140 | Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry | 001 | 2 | NIH | 12/5/2023 | $0 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AT012140 | Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry | 000 | 2 | NIH | 10/26/2023 | -$29,950 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AT012140 | Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry | 000 | 2 | NIH | 10/26/2023 | $29,950 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | P20ES036110 | Climate & Health Actionable Research and Translation Center | 000 | 1 | NIH | 10/27/2023 | $0 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | P01HL154996 | Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS) | 000 | 2 | NIH | 10/26/2023 | $0 |
| 2024 | 2023 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI172377 | Differentiation of memory B cells requires EZH2 and epigenetic remodeling | 000 | 1 | NIH | 10/30/2023 | $0 |
|